Patrick BAEUERLE,Gregory SIECZKIEWICZ,Robert HOFMEISTER
申请号:
US15419398
公开号:
US20170166622A1
申请日:
2017.01.30
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Provided herein are T-cell receptor (TCR) fusion proteins (TFPs), T-cells engineered to express one or more TFPs, and methods of use thereof for the treatment of diseases, including cancer.